Eyenovia, Inc. (EYEN) Financials

EYEN Assets vs Liabilities

DateAssetsLiabilities
2023-12-31 28.8 million 19.8 million
2023-09-30 34.9 million 19.1 million
2023-06-30 29.3 million 18.8 million
2023-03-31 29.3 million 13.5 million

EYEN Free Cash Flow and Stock based compensation

Graph available only for supporters. Become a supporter to see it.
DateFree Cash FlowStock based compensation
2023-12-31 -6.5 million 572225
2023-09-30 -7.5 million 612969
2023-06-30 -5.9 million 493632
2023-03-31 -7.9 million 819064

EYEN Net Income

No data available :(

EYEN Cash and Debt

Graph available only for supporters. Become a supporter to see it.
DateCashDebtCapital Lease
2023-12-31 14.8 million - 1.8 million
2023-09-30 20.7 million - 1.9 million
2023-06-30 17.5 million 13.2 million 2.0 million
2023-03-31 18.5 million 7.5 million 1.6 million

EYEN Shares Outstanding

Graph available only for supporters. Become a supporter to see it.
DateShares Outstanding
2023-12-31 45.4 million
2023-09-30 40.1 million
2023-06-30 38.1 million
2023-03-31 37.4 million

EYEN Expenses

Graph available only for supporters. Become a supporter to see it.
DateCapexR&DG&AS&M
2023-12-31 145231 3.8 million 2.9 million 496533
2023-09-30 1.7 million 3.6 million 2.9 million 203733
2023-06-30 1.2 million 2.8 million 3.1 million 201516
2023-03-31 920865 2.5 million 2.9 million 195620

EYEN Cost of Revenue

Graph available only for supporters. Become a supporter to see it.
DateRevenueCost of Revenue
2023-12-31 2589 280113
2023-09-30 1198 1198
2023-06-30 - 271209
2023-03-31 - 197026

EYEN

Price: $0.63

52 week price:
0.50
5.85

Earnings Per Share: -0.66 USD

P/E Ratio: -2.70

Exchange: NCM

Sector: Healthcare

Industry: Biotechnology

Volume: 305981

Market Capitalization: 25.1 million

Links: